Dustin R. Glasner

University of California, San Francisco — United States

Medicine · Health Sciences

19h-index3.4kcitations36works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(15), Viral Infections and Vectors(13), Malaria Research and Control(9), COVID-19 Clinical Research Studies(6), SARS-CoV-2 and COVID-19 Research(6)

Publications36 total

Flavivirus NS1-triggered endothelial dysfunction promotes virus dissemination
PLoS Pathogens·2025Open Access
Correction: Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
eLife·2025Open Access
The IFIT2–IFIT3 antiviral complex targets short 5’ untranslated regions on viral mRNAs for translation inhibition
Nature Microbiology·2025· 2 citedOpen Access
RNA Host Response-Based Diagnosis of Tick-Borne Infections using Machine Learning and Generative Artificial Intelligence
2025Open Access
Short 5’ UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex
2025· 1 citedOpen Access
Flavivirus NS1-triggered endothelial dysfunction promotes virus dissemination
2024· 5 citedOpen Access
Unchecked growth: Pushing the limits on RNA virus genome size in the absence of known proofreading
Proceedings of the National Academy of Sciences·2024· 1 citedOpen Access
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Nature Communications·2022· 72 citedOpen Access
Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3β-Dependent Manner
Pathogens·2022· 37 citedOpen Access
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Nature Microbiology·2022· 46 cited
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
2021· 12 citedOpen Access
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
2021· 13 citedOpen Access
Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
eLife·2021· 29 citedOpen Access
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Cell·2021· 537 citedOpen Access
Author response: Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
2021· 1 citedOpen Access
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
2021· 247 citedOpen Access
Author Reply to Peer Reviews of Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
2021
Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction
Science·2021· 144 citedOpen Access
Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
2020· 3 citedOpen Access
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Nature Communications·2020· 181 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Eva Harris(19), Henry Puerta‐Guardo(11), Diego A. Espinosa(10), Venice Servellita(9), P. Robert Beatty(9), Scott B. Biering(8), Kevin Reyes(7), Charles Y. Chiu(7), Candace Wang(6), Alicia Sotomayor-González(6), Steve Miller(6), Amelia S. Gliwa(5), Yale Santos(5), Nicholas T. N. Lo(5), Thomas Burke(5), Patrik Engström(5), Cuong J. Tran(5), Matthew D. Welch(5), Xianding Deng(4), Joanna Balcerek(4)